Home / Publications / New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines

New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines

Dmitriy Yurievich Vandyshev 1
Dmitriy Yurievich Vandyshev
Khidmet Sapharovich Shikhaliev 1
Khidmet Sapharovich Shikhaliev
Mikhail Yur'evich Krysin 1
Mikhail Yur'evich Krysin
Tatiana Nikolaevna Ilyinova 2
Tatiana Nikolaevna Ilyinova
Daria A Mangusheva 1
Daria A Mangusheva
Oleg Evgen'evich Sidorenko 1
Oleg Evgen'evich Sidorenko
Renata Rustamovna Iminova 1
Renata Rustamovna Iminova
Published 2022-09-05
CommunicationVolume 32, Issue 5, 637-639
2
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Vandyshev D. Y. et al. New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines // Mendeleev Communications. 2022. Vol. 32. No. 5. pp. 637-639.
GOST all authors (up to 50) Copy
Vandyshev D. Y., Shikhaliev K. S., Krysin M. Y., Ilyinova T. N., Mangusheva D. A., Sidorenko O. E., Iminova R. R. New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines // Mendeleev Communications. 2022. Vol. 32. No. 5. pp. 637-639.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2022.09.023
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.09.023
TI - New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines
T2 - Mendeleev Communications
AU - Vandyshev, Dmitriy Yurievich
AU - Shikhaliev, Khidmet Sapharovich
AU - Krysin, Mikhail Yur'evich
AU - Ilyinova, Tatiana Nikolaevna
AU - Mangusheva, Daria A
AU - Sidorenko, Oleg Evgen'evich
AU - Iminova, Renata Rustamovna
PY - 2022
DA - 2022/09/05
PB - Mendeleev Communications
SP - 637-639
IS - 5
VL - 32
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Vandyshev,
author = {Dmitriy Yurievich Vandyshev and Khidmet Sapharovich Shikhaliev and Mikhail Yur'evich Krysin and Tatiana Nikolaevna Ilyinova and Daria A Mangusheva and Oleg Evgen'evich Sidorenko and Renata Rustamovna Iminova},
title = {New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines},
journal = {Mendeleev Communications},
year = {2022},
volume = {32},
publisher = {Mendeleev Communications},
month = {Sep},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.09.023},
number = {5},
pages = {637--639},
doi = {10.1016/j.mencom.2022.09.023}
}
MLA
Cite this
MLA Copy
Vandyshev, Dmitriy Yurievich, et al. “New regio/chemoselective synthesis of hydrogenated imidazo[1,5-b]pyridazines.” Mendeleev Communications, vol. 32, no. 5, Sep. 2022, pp. 637-639. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.09.023.

Keywords

1,2-diamino-4-phenylimidazole
arylidenecyanoacetates
cascade processes
diastereomers
imidazo[1,5-b]pyridazines
quantum chemical calculations
regioselectivity

Abstract

The cascade heterocyclization of 1,2-diamino-4-phenyl-imidazole with ethyl 2-arylidene-2-cyanoacetates affords 1,2,3,4-tetrahydroimidazo[1,5-b]pyridazine-3-carbonitrile derivatives as mixtures of diastereomers. The experimental data and quantum chemical calculations were used to propose processes. The three-component processing with above-mentioned diamine, ethyl cyanoacetate and aromatic aldehydes leads to the same products in generally lower yields.

References

1.
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)
Murray C.W., Rees D.C.
Angewandte Chemie - International Edition, 2015
2.
Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD)
Palmer N., Peakman T.M., Norton D., Rees D.C.
Organic and Biomolecular Chemistry, 2016
4.
Partially Saturated Bicyclic Heteroaromatics as an sp3 -Enriched Fragment Collection
Twigg D.G., Kondo N., Mitchell S.L., Galloway W.R., Sore H.F., Madin A., Spring D.R.
Angewandte Chemie - International Edition, 2016
5.
Design and synthesis of a fragment set based on twisted bicyclic lactams
Hassan H., Marsden S.P., Nelson A.
Bioorganic and Medicinal Chemistry, 2018
6.
Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library
Lüthy M., Wheldon M.C., Haji-Cheteh C., Atobe M., Bond P.S., O’Brien P., Hubbard R.E., Fairlamb I.J.
Bioorganic and Medicinal Chemistry, 2015
7.
Practical synthesis of pharmaceutically relevant molecules enriched in sp3 character
Campbell P.S., Jamieson C., Simpson I., Watson A.J.
Chemical Communications, 2018
8.
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering F., Bikker J., Humblet C.
Journal of Medicinal Chemistry, 2009
10.
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann M.M., Leach A.R., Harper G.
Journal of Chemical Information and Computer Sciences, 2001
11.
A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas
Foulks J.M., Carpenter K.J., Luo B., Xu Y., Senina A., Nix R., Chan A., Clifford A., Wilkes M., Vollmer D., Brenning B., Merx S., Lai S., McCullar M.V., Ho K., et. al.
Neoplasia, 2014
12.
T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin
Rimoli M.G., Russo E., Cataldi M., Citraro R., Ambrosino P., Melisi D., Curcio A., De Lucia S., Patrignani P., De Sarro G., Abignente E.
Neuropharmacology, 2009
13.
Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)
Chapman T.M., Osborne S.A., Bouloc N., Large J.M., Wallace C., Birchall K., Ansell K.H., Jones H.M., Taylor D., Clough B., Green J.L., Holder A.A.
Bioorganic and Medicinal Chemistry Letters, 2013
14.
J. Kehler, L. K. Rasmussen, M. Langgård, M. Jessing, P.J.V. Vital, K. Juhl, M. Marigo, Patent WO 2019/121840 A1, 2019.
15.
R.T. Skerlj, E.M.J. Bourque, W.J. Greenlee, P.T. Lansbury, Patent WO 2017/192930, 2017.
16.
C. Hirth-Dietrich, P. Sandner, J.-P. Stasch, M. Hahn, M. Follmann, Vakalopoulos, Patent WO 2016/177660 A1, 2016.
17.
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Follmann M., Ackerstaff J., Redlich G., Wunder F., Lang D., Kern A., Fey P., Griebenow N., Kroh W., Becker-Pelster E., Kretschmer A., Geiss V., Li V., Straub A., Mittendorf J., et. al.
Journal of Medicinal Chemistry, 2017
18.
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors
Kaieda A., Takahashi M., Takai T., Goto M., Miyazaki T., Hori Y., Unno S., Kawamoto T., Tanaka T., Itono S., Takagi T., Hamada T., Shirasaki M., Okada K., Snell G., et. al.
Bioorganic and Medicinal Chemistry, 2018
19.
Lipson V.V., Svetlichnaya N.V., Shishkina S.V., Shishkin O.V.
Mendeleev Communications, 2008
20.
A novel synthetic approach to hydroimidazo[1,5-b]pyridazines by the recyclization of itaconimides and HPLC–HRMS monitoring of the reaction pathway
Vandyshev D.Y., Shikhaliev K.S., Potapov A.Y., Krysin M.Y., Zubkov F.I., Sapronova L.V.
Beilstein Journal of Organic Chemistry, 2017
21.
Condensation of 1,2-diamino-4-phenylimidazole and N-arylmaleimides with the formation of new tetrahydroimidazo[1,5-b]pyridazines
Vandyshev D.Y., Shikhaliev K.S., Potapov A.Y., Krysin M.Y.
Chemistry of Heterocyclic Compounds, 2015
22.
10.1016/j.mencom.2022.09.023_b0110
El-Gazzar
Egypt. J. Chem., 2003
25.
An efficient Sn(ii)-catalyzed one-pot synthesis of a 3-substituted azetidine-2,4-dione framework
Chavan S.S., Supekar M.V., Burate P.A., Rupanwar B.D., Shelke A.M., Suryavanshi G.
Organic and Biomolecular Chemistry, 2017
29.
Yu. Vandyshev D., Kosheleva E.A., Polikarchuk V.A., Mangusheva D.A., Denisov G.L., Shikhaliev K.S.
Mendeleev Communications, 2021
31.
Iron-catalyzed domino decarboxylation-oxidation of α,β-unsaturated carboxylic acids enabled aldehyde C–H methylation
Gong P., Xu F., Cheng L., Gong X., Zhang J., Gu W., Han W.
Chemical Communications, 2021
32.
Length-Selective Synthesis of Acylglycerol-Phosphates through Energy-Dissipative Cycling
Bonfio C., Caumes C., Duffy C.D., Patel B.H., Percivalle C., Tsanakopoulou M., Sutherland J.D.
Journal of the American Chemical Society, 2019